Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Overview

This guidance document has been developed as a reference for countries to support the development and delivery of national action plans on antimicrobial resistance. It provides assistance on how to establish a monitoring and evaluation plan for their AMR NAP, building on existing national reporting systems and recommended indicators from the Global Action Plan on AMR M&E framework. The guidance emphasizes the need for effective governance for AMR NAP development, implementation and monitoring but does not suggest indicators for the GAP-AMR’s fifth strategic objective (investment in research and development) as this was viewed as an aspirational outcome for many countries; or for indicators specific to HIV, tuberculosis or malaria control programmes, which are monitored and evaluated by those individual disease control programmes.

This guidance document is intended for members of the AMR multisectoral coordination committee or working group, persons responsible for M&E in AMR NAPs and other key actors involved in NAP implementation. The guidance may also be useful for M&E experts and One Health coordination committee members at the national and subnational levels.